ALX Oncology grants General Counsel Listgarten option for 500,000 shares at $2.20 each

ALX Oncology Holdings

ALX Oncology Holdings

ALXO

0.00
  • ALX Oncology granted General Counsel Michael Listgarten an inducement stock option for 500,000 common shares on June 29, 2026.
  • Exercise price set at $2.2 per share, matching the stock’s closing price on the grant date.
  • Vesting terms: 25% on June 29, 2027; remaining shares vest monthly in 1/48 increments, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606301640PRIMZONEFULLFEED9755139) on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.